Skip to main content
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published loading...Updated

FDA Issues Nationwide Recall of Certain Thyroid Medications Sold by Major Rugby: See the List

The company said 12 levothyroxine tablet packages were affected, and officials said the pills may deliver less medication than intended.

  • On July 13, pharmaceutical manufacturer Major Rugby issued a nationwide recall for 12 packages of levothyroxine sodium tablets used to treat hypothyroidism and thyroid-related conditions, according to a letter sent to retailers.
  • According to the Food and Drug Administration , the recalled pills are "subpotent," meaning they deliver less medication than intended; the Mayo Clinic notes these tablets treat enlarged thyroid glands and cancer, distributed nationwide beginning January 22, 2025.
  • Affected packages include 100-tablet and 10-tablet unit dose blister packs, with specific lot numbers ranging from N02167 to N02310. The recall encompasses various dosages, including 0.025 mg, 0.050 mg, 0.075 mg, 0.088 mg, 0.112 mg, 0.125 mg, and 0.150 mg.
  • "Taking the tablets is not likely to cause adverse health effects," Major Rugby stated in its letter. Consumers are urged to return the medicine to the point of purchase and consult a doctor if they find affected product.
  • Customers seeking further details can visit the company's website. The medication was sold nationwide under both the Major Rugby and Cardinal brand names since January 2025, positioning the recall across multiple distribution channels.
Insights by Ground AI

25 Articles

FOX13newsFOX13news
+9 Reposted by 9 other sources
Center

FDA issues nationwide recall of certain thyroid medications sold by Major Rugby: See the list

Certain lots of thyroid medication sold nationwide by Major Rugby have been recalled due to it being "subpotent," meaning, the drug won't deliver as much medication as intended.

·Florida, United States
Read Full Article
KYTXKYTX
+9 Reposted by 9 other sources
Center

Thyroid medication described as 'subpotent drug' recalled by FDA

As a Class II recall, the FDA warned that the thyroid drug could cause "temporary or medically reversible adverse health consequences."

Earlier this month, pharmaceutical company Major Rugby sent a letter to retailers announcing a nationwide recall of a common thyroid medication, levothyroxine sodium tablets (LT4).

·New York, United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 83% of the sources are Center
83% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

WKYC broke the news in Cleveland, United States on Monday, July 27, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal